{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/LDX.AU/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"LDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","market":"AU","secType":"STK","nameCN":"LUMOS DIAGNOSTICS HOLDINGS L","latestPrice":0.107,"timestamp":1789533657013,"preClose":0.11,"halted":0,"volume":457544,"delay":0,"changeRate":-0.027272727272727296,"nameEN":"LUMOS DIAGNOSTICS HOLDINGS L","floatShares":375602340,"shares":944389135,"eps":-0.008557019912606174,"marketStatus":"交易中","change":-0.003,"latestTime":"09-16 14:44:11 AEST","open":0.11,"high":0.112,"low":0.105,"amount":50177,"amplitude":0.063636,"askPrice":0.11,"askSize":182238,"bidPrice":0.105,"bidSize":899445,"shortable":3,"etf":0,"ttmEps":-0.008557019912606174,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789538400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.11,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.282518,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"LDX.AU","preClose":0.11,"auctionPrice":0.11,"auctionVolume":5000,"auctionTime":1789516741715,"referenceTime":1789468203091,"auction":1,"marketStatus":"盘前竞价","timestamp":1789516741715}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"LDX.AU\",,,,,undefined,":{"symbol":"LDX.AU","floatShares":375602340,"roa":"-28.69%","roe":"-34.13%","lyrEps":-0.008557,"volumeRatio":0.282518,"shares":944389135,"dividePrice":0,"high":0.112,"amplitude":0.063636,"preClose":0.11,"low":0.105,"week52Low":0.076,"pbRate":"3.15","psRate":"5.46","week52High":0.33,"institutionHeld":0,"latestPrice":0.107,"committee":0.663047,"eps":-0.008557019912606174,"divideRate":0,"volume":457544,"delay":0,"ttmEps":-0.008557019912606174,"open":0.11,"prevYearClose":0.285,"prevWeekClose":0.1,"prevMonthClose":0.105,"prevQuarterClose":0.105,"fiveDayClose":0.11,"twentyDayClose":0.105,"sixtyDayClose":0.105,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-07-27","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1785110400000,"name":null,"time":"","dateTimestamp":1785074400000,"actualEps":null},{"date":"2026-04-20","symbol":"LDX.AU","type":"earning","reportTimeType":"post","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1776643200000,"name":null,"time":"盤後","dateTimestamp":1776607200000,"actualEps":null},{"date":"2025-08-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2024-07-31","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1722384000000,"name":null,"time":"","dateTimestamp":1722348000000,"actualEps":null},{"date":"2024-02-28","symbol":"LDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1709074800000,"name":null,"time":"","dateTimestamp":1709038800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDX.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1134059989","title":"Lumos Diagnostics 2026財年營收增長6%，達1320萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1134059989","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134059989?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 09:42","pubTimestamp":1785116568,"startTime":"0","endTime":"0","summary":"在2026财年，Lumos Diagnostics Holdings Ltd（LUMOS DIAGNOSTICS HOLDINGS L）交出了一份亮眼的成绩单。公司营业收入同比攀升6%，总额达到1320万美元。这一数据，不仅反映了其在诊断领域的持续深耕，也彰显了市场对其产品的强劲需求。从财务表现来看，稳健的增长势头为这家企业注入了更多信心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","LDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128307929","title":"Lumos Diagnostics Holdings 尋求交易暫停，等待FDA對Febridx CLIA豁免申請的回應更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1128307929","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128307929?lang=zh_tw&edition=fundamental","pubTime":"2026-03-25 06:22","pubTimestamp":1774390934,"startTime":"0","endTime":"0","summary":"Lumos Diagnostics Holdings（ASX: LDX）已向澳大利亚证券交易所申请交易暂停，以待公司就美国食品药品监督管理局（FDA）对其Febridx检测产品CLIA豁免申请的回应发布最新消息。\n该交易暂停将自2023年10月11日开盘时生效，直至公司发布相关公告或10月13日开盘时终止，以较早者为准。此举旨在确保在重要监管信息发布前，市场交易的公平性和有序性。\nFebridx是公司开发的一款快速诊断产品，CLIA豁免意味着该产品可在更广泛的医疗点（如诊所、药房）由非专业人员使用，从而显著扩大其市场潜力。此次FDA的回应对于该产品在美国的商业化进程至关重要。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LDX.AU","BK7126"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}]}}